{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T13:14:10Z","timestamp":1774358050059,"version":"3.50.1"},"reference-count":63,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2025,2,26]],"date-time":"2025-02-26T00:00:00Z","timestamp":1740528000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,2,26]],"date-time":"2025-02-26T00:00:00Z","timestamp":1740528000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100000646","name":"Japan Society for the Promotion of Science London","doi-asserted-by":"publisher","award":["22K07252"],"award-info":[{"award-number":["22K07252"]}],"id":[{"id":"10.13039\/501100000646","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancer Gene Ther"],"published-print":{"date-parts":[[2025,3]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>Muscle-invasive bladder cancer (MIBC), a highly heterogeneous disease, shows genomic instability and a high mutation rate, making it difficult to treat. Recent studies revealed that cancer stem cells (CSCs) play a critical role in MIBC frequent recurrence and high morbidity. Previous research has shown that Cyclooxygenases-2 (COX-2) is particularly highly expressed in bladder cancer cells. In recent years, the development of oncolytic adenoviruses and their use in clinical trials have gained increased attention. In this study, we composed a conditionally replicative adenovirus vector (CRAd-synNotch) that carries the COX-2 promotor driving adenoviral <jats:italic>E1<\/jats:italic> gene, the <jats:italic>synNotch<\/jats:italic> receptor therapeutic gene, and the <jats:italic>Ad5\/35 fiber<\/jats:italic> gene. Activation of the COX-2 promoter gene causes replication only within COX-2 expressing cancer cells, thereby leading to tumor oncolysis. Also, CD44 and HIF signals contribute to cancer stemness and maintaining CSCs in bladder cancer, and the transduced synNotch receptor inhibits both CD44 and HIF signals simultaneously. We performed an in vivo study using a mouse xenograft model of T24 human MIBC cells and confirmed the significant antitumor activity of CRAd-synNotch. Our findings in this study warrant the further development of CRAd-synNotch for treating patients with MIBC.<\/jats:p>","DOI":"10.1038\/s41417-025-00879-8","type":"journal-article","created":{"date-parts":[[2025,2,26]],"date-time":"2025-02-26T11:30:26Z","timestamp":1740569426000},"page":"306-317","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["A conditionally replicative adenovirus vector containing the synNotch receptor gene for the treatment of muscle-invasive bladder cancer"],"prefix":"10.1038","volume":"32","author":[{"given":"Ruhan","family":"A","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7742-4528","authenticated-orcid":false,"given":"Hideto","family":"Ueki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shunya","family":"Nishioka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rion","family":"Yamazaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marina","family":"Maekawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4508-2671","authenticated-orcid":false,"given":"Koichi","family":"Kitagawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hideaki","family":"Miyake","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3925-8730","authenticated-orcid":false,"given":"Toshiro","family":"Shirakawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,2,26]]},"reference":[{"key":"879_CR1","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71:209\u201349.","journal-title":"CA Cancer J Clin"},{"key":"879_CR2","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1111\/bju.12601","volume":"114","author":"AB Smith","year":"2014","unstructured":"Smith AB, Deal AM, Woods ME, Wallen EM, Pruthi RS, Chen RC, et al. Muscle-invasive bladder cancer: evaluating treatment and survival in the national cancer data base. BJU Int. 2014;114:719\u201326.","journal-title":"BJU Int"},{"key":"879_CR3","doi-asserted-by":"publisher","first-page":"2796","DOI":"10.1016\/S0140-6736(16)30512-8","volume":"388","author":"AM Kamat","year":"2016","unstructured":"Kamat AM, Hahn NM, Efstathiou JA, Lerner SP, Malmstr\u00f6m PU, Choi W, et al. Bladder cancer. Lancet. 2016;388:2796\u2013810.","journal-title":"Lancet"},{"key":"879_CR4","doi-asserted-by":"publisher","first-page":"404","DOI":"10.3322\/caac.21631","volume":"70","author":"VG Patel","year":"2020","unstructured":"Patel VG, Oh WK, Galsky MD. Treatment of muscle-invasive and advanced bladder cancer in 2020. CA Cancer J Clin. 2020;70:404\u201323.","journal-title":"CA Cancer J Clin"},{"key":"879_CR5","doi-asserted-by":"publisher","first-page":"1587","DOI":"10.21037\/atm-20-2108","volume":"8","author":"Y Zang","year":"2020","unstructured":"Zang Y, Li X, Cheng Y, Qi F, Yang N. An overview of patients with urothelial bladder cancer over the past two decades: a surveillance, epidemiology, and end results (SEER) study. Ann Transl Med. 2020;8:1587.","journal-title":"Ann Transl Med"},{"key":"879_CR6","doi-asserted-by":"publisher","first-page":"43","DOI":"10.3390\/ijms17010043","volume":"17","author":"T Ohishi","year":"2015","unstructured":"Ohishi T, Koga F, Migita T. Bladder cancer stem-like cells: their origin and therapeutic perspectives. Int J Mol Sci. 2015;17:43.","journal-title":"Int J Mol Sci"},{"key":"879_CR7","doi-asserted-by":"publisher","first-page":"974","DOI":"10.1002\/stem.1625","volume":"32","author":"GM Dancik","year":"2014","unstructured":"Dancik GM, Owens CR, Iczkowski KA, Theodorescu D. A cell of origin gene signature indicates human bladder cancer has distinct cellular progenitors. Stem Cells. 2014;32:974\u201382.","journal-title":"Stem Cells"},{"key":"879_CR8","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2022.904536","volume":"13","author":"J Yao","year":"2022","unstructured":"Yao J, Liu Y, Yang J, Li M, Li S, Zhang B, et al. Single-cell sequencing reveals that DBI is the key gene and potential therapeutic target in quiescent bladder cancer stem cells. Front Genet. 2022;13:904536.","journal-title":"Front Genet"},{"key":"879_CR9","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1080\/09674845.2019.1692761","volume":"77","author":"Z Siddiqui","year":"2020","unstructured":"Siddiqui Z, Srivastava AN, Sankhwar SN, Dalela D, Singh V, Zaidi N, et al. Synergic effects of cancer stem cells markers, CD44 and embryonic stem cell transcription factor Nanog, on bladder cancer prognosis. Br J Biomed Sci. 2020;77:69\u201375.","journal-title":"Br J Biomed Sci"},{"key":"879_CR10","doi-asserted-by":"publisher","first-page":"e103","DOI":"10.1097\/CAD.0000000000001153","volume":"33","author":"W Wang","year":"2022","unstructured":"Wang W, Zhang M, Huang Z, Wang L, Yue Y, et al. Knockdown of CXCL5 inhibits the invasion, metastasis and stemness of bladder cancer lung metastatic cells by downregulating CD44. Anticancer Drugs. 2022;33:e103\u201312.","journal-title":"Anticancer Drugs"},{"key":"879_CR11","doi-asserted-by":"publisher","first-page":"3518","DOI":"10.1245\/s10434-018-6706-0","volume":"25","author":"CT Wu","year":"2018","unstructured":"Wu CT, Lin WY, Chen WC, Chen MF. Predictive value of CD44 in muscle-invasive bladder cancer and its relationship with IL-6 signaling. Ann Surg Oncol. 2018;25:3518\u201326.","journal-title":"Ann Surg Oncol"},{"key":"879_CR12","doi-asserted-by":"publisher","DOI":"10.1590\/1414-431x20176768","volume":"51","author":"C Liu","year":"2017","unstructured":"Liu C, Shui CL, Wang Q, Luo H, Gu CG. Mechanism of hif-1\u03b1 mediated hypoxia-induced permeability changes in bladder endothelial cells. Braz J Med Biol Res. 2017;51:e6768.","journal-title":"Braz J Med Biol Res"},{"key":"879_CR13","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2023.1222575","volume":"13","author":"RF Zaarour","year":"2023","unstructured":"Zaarour RF, Ribeiro M, Azzarone B, Kapoor S, Chouaib S. Tumor microenvironment-induced tumor cell plasticity: relationship with hypoxic stress and impact on tumor resistance. Front Oncol. 2023;13:1222575.","journal-title":"Front Oncol"},{"key":"879_CR14","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1016\/j.ccr.2009.03.018","volume":"15","author":"Z Li","year":"2009","unstructured":"Li Z, Bao S, Wu Q, Wang H, Eyler C, Sathornsumetee S, et al. Hypoxia-inducible factors regulate tumorigenic capacity of glioma stem cells. Cancer Cell. 2009;15:501\u201313.","journal-title":"Cancer Cell"},{"key":"879_CR15","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.critrevonc.2017.02.025","volume":"113","author":"R Vadde","year":"2017","unstructured":"Vadde R, Vemula S, Jinka R, Merchant N, Bramhachari PV, Nagaraju GP. Role of hypoxia-inducible factors (HIF) in the maintenance of stemness and malignancy of colorectal cancer. Crit Rev Oncol Hematol. 2017;113:22\u20137.","journal-title":"Crit Rev Oncol Hematol"},{"key":"879_CR16","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1016\/j.molcel.2008.04.009","volume":"30","author":"WG Kaelin Jr","year":"2008","unstructured":"Kaelin WG Jr, Ratcliffe PJ. Oxygen sensing by metazoans: the central role of the HIF hydroxylase pathway. Mol Cell. 2008;30:393\u2013402.","journal-title":"Mol Cell"},{"key":"879_CR17","doi-asserted-by":"publisher","first-page":"1396","DOI":"10.1096\/fj.05-3788com","volume":"19","author":"MA Maynard","year":"2005","unstructured":"Maynard MA, Evans AJ, Hosomi T, Hara S, Jewett MA, Ohh M. Human HIF-3alpha4 is a dominant-negative regulator of HIF-1 and is down-regulated in renal cell carcinoma. FASEB J. 2005;19:1396\u2013406.","journal-title":"FASEB J"},{"key":"879_CR18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/0092-8674(77)90180-5","volume":"12","author":"LT Chow","year":"1977","unstructured":"Chow LT, Gelinas RE, Broker TR, Roberts RJ. An amazing sequence arrangement at the 5\u2019 ends of adenovirus 2 messenger RNA. Cell. 1977;12:1\u20138.","journal-title":"Cell"},{"key":"879_CR19","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/0092-8674(86)90386-7","volume":"45","author":"I Kovesdi","year":"1986","unstructured":"Kovesdi I, Reichel R, Nevins JR. Identification of a cellular transcription factor involved in E1A trans-activation. Cell. 1986;45:219\u201328.","journal-title":"Cell"},{"key":"879_CR20","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1038\/ncb2956","volume":"16","author":"K Shin","year":"2014","unstructured":"Shin K, Lim A, Odegaard JI, Honeycutt JD, Kawano S, Hsieh MH, et al. Cellular origin of bladder neoplasia and tissue dynamics of its progression to invasive carcinoma. Nat Cell Biol. 2014;16:469\u201378.","journal-title":"Nat Cell Biol"},{"key":"879_CR21","doi-asserted-by":"publisher","first-page":"1280","DOI":"10.3389\/fimmu.2020.01280","volume":"11","author":"L Walcher","year":"2020","unstructured":"Walcher L, Kistenmacher AK, Suo H, Kitte R, Dluczek S, Strau\u00df A, et al. Cancer stem cells-origins and biomarkers: perspectives for targeted personalized therapies. Front Immunol. 2020;11:1280.","journal-title":"Front Immunol"},{"key":"879_CR22","doi-asserted-by":"publisher","first-page":"732","DOI":"10.3390\/cancers11050732","volume":"11","author":"M Shibata","year":"2019","unstructured":"Shibata M, Hoque MO. Targeting cancer stem cells: a strategy for effective eradication of cancer. Cancers (Basel). 2019;11:732.","journal-title":"Cancers (Basel)"},{"key":"879_CR23","first-page":"4906","volume":"59","author":"T Kijima","year":"1999","unstructured":"Kijima T, Osaki T, Nishino K, Kumagai T, Funakoshi T, Goto H, et al. Application of the Cre recombinase\/loxP system further enhances antitumor effects in cell type-specific gene therapy against carcinoembryonic antigen-producing cancer. Cancer Res. 1999;59:4906\u201311.","journal-title":"Cancer Res"},{"key":"879_CR24","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.mam.2015.09.004","volume":"47-48","author":"GL Semenza","year":"2016","unstructured":"Semenza GL. Dynamic regulation of stem cell specification and maintenance by hypoxia-inducible factors. Mol Aspects Med. 2016;47-48:15\u201323.","journal-title":"Mol Aspects Med"},{"key":"879_CR25","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2023.1147668","volume":"13","author":"A Ruhan","year":"2023","unstructured":"Ruhan A, Kunimura N, Tominaga S, Hirata E, Nishioka S, Uesugi M, et al. A recombinant adenovirus vector containing the synNotch receptor gene for the treatment of triple-negative breast cancer. Front Oncol. 2023;13:1147668.","journal-title":"Front Oncol"},{"key":"879_CR26","doi-asserted-by":"publisher","first-page":"4342","DOI":"10.1158\/1078-0432.CCR-03-0267","volume":"10","author":"T Shirakawa","year":"2004","unstructured":"Shirakawa T, Hamada K, Zhang Z, Okada H, Tagawa M, Kamidono S, et al. A cox-2 promoter-based replication-selective adenoviral vector to target the cox-2-expressing human bladder cancer cells. Clin Cancer Res. 2004;10:4342\u20138.","journal-title":"Clin Cancer Res"},{"key":"879_CR27","first-page":"847","volume":"63","author":"A Hemminki","year":"2003","unstructured":"Hemminki A, Kanerva A, Liu B, Wang M, Alvarez RD, Siegal GP, et al. Modulation of coxsackie-adenovirus receptor expression for increased adenoviral transgene expression. Cancer Res. 2003;63:847\u201353.","journal-title":"Cancer Res"},{"key":"879_CR28","doi-asserted-by":"publisher","first-page":"2694","DOI":"10.3390\/ijms19092694","volume":"19","author":"MH Do","year":"2018","unstructured":"Do MH, To PK, Cho YS, Kwon SY, Hwang EC, Choi C, et al. Targeting CD46 enhances anti-tumoral activity of adenovirus type 5 for bladder cancer. Int J Mol Sci. 2018;19:2694.","journal-title":"Int J Mol Sci"},{"key":"879_CR29","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2407-14-713","volume":"14","author":"T Suzuki","year":"2014","unstructured":"Suzuki T, Kawamura K, Li Q, Okamoto S, Tada Y, Tatsumi K, et al. Mesenchymal stem cells are efficiently transduced with adenoviruses bearing type 35-derived fibers and the transduced cells with the IL-28A gene produces cytotoxicity to lung carcinoma cells co-cultured. BMC Cancer. 2014;14:713.","journal-title":"BMC Cancer"},{"key":"879_CR30","first-page":"5201","volume":"35","author":"T Kosaka","year":"2015","unstructured":"Kosaka T, Davydova J, Ono HA, Akiyama H, Hirai S, Ohno S, et al. Imaging and antitumoral effect of a cyclo-oxygenase 2-specific replicative adenovirus for small metastatic gastric cancer lesions. Anticancer Res. 2015;35:5201\u201310.","journal-title":"Anticancer Res"},{"key":"879_CR31","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.3390\/vaccines9111249","volume":"9","author":"A Berg","year":"2021","unstructured":"Berg A, Wright D, Dulal P, Stedman A, Fedosyuk S, Francis MJ, et al. Stability of chimpanzee adenovirus vectored vaccines (ChAdOx1 and ChAdOx2) in liquid and lyophilised formulations. Vaccines (Basel). 2021;9:1249.","journal-title":"Vaccines (Basel)"},{"key":"879_CR32","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1038\/cgt.2017.21","volume":"24","author":"H Saito","year":"2017","unstructured":"Saito H, Kitagawa K, Yoneda T, Fukui Y, Fujsawa M, Bautista D, et al. Combination of p53-DC vaccine and rAd-p53 gene therapy induced CTLs cytotoxic against p53-deleted human prostate cancer cells in vitro. Cancer Gene Ther. 2017;24:289\u201396.","journal-title":"Cancer Gene Ther"},{"key":"879_CR33","doi-asserted-by":"publisher","first-page":"1320","DOI":"10.1126\/science.275.5304.1320","volume":"275","author":"JM Bergelson","year":"1997","unstructured":"Bergelson JM, Cunningham JA, Droguett G, Kurt-Jones EA, Krithivas A, Hong JS, et al. Isolation of a common receptor for Coxsackie B viruses and adenoviruses 2 and 5. Science. 1997;275:1320\u20133.","journal-title":"Science"},{"key":"879_CR34","doi-asserted-by":"publisher","first-page":"1056","DOI":"10.1016\/S1734-1140(13)71465-8","volume":"65","author":"MS Karbownik","year":"2013","unstructured":"Karbownik MS, Nowak JZ. Hyaluronan: towards novel anti-cancer therapeutics. Pharmacol Rep. 2013;65:1056\u201374.","journal-title":"Pharmacol Rep."},{"key":"879_CR35","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/B978-0-12-800092-2.00002-2","volume":"123","author":"VB Lokeshwar","year":"2014","unstructured":"Lokeshwar VB, Mirza S, Jordan A. Targeting hyaluronic acid family for cancer chemoprevention and therapy. Adv Cancer Res. 2014;123:35\u201365.","journal-title":"Adv Cancer Res"},{"key":"879_CR36","doi-asserted-by":"publisher","DOI":"10.1186\/1479-5876-11-216","volume":"11","author":"K Mantwill","year":"2013","unstructured":"Mantwill K, Naumann U, Seznec J, Girbinger V, Lage H, Surowiak P, et al. YB-1 dependent oncolytic adenovirus efficiently inhibits tumor growth of glioma cancer stem like cells. J Transl Med. 2013;11:216.","journal-title":"J Transl Med"},{"key":"879_CR37","doi-asserted-by":"publisher","first-page":"10522","DOI":"10.3390\/ijms221910522","volume":"22","author":"K Mantwill","year":"2021","unstructured":"Mantwill K, Klein FG, Wang D, Hindupur SV, Ehrenfeld M, Holm PS, et al. Concepts in oncolytic adenovirus therapy. Int J Mol Sci. 2021;22:10522.","journal-title":"Int J Mol Sci"},{"key":"879_CR38","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1016\/j.cell.2016.09.011","volume":"167","author":"KT Roybal","year":"2016","unstructured":"Roybal KT, Williams JZ, Morsut L, Rupp LJ, Kolinko I, Choe JH, et al. Engineering T cells with customized therapeutic response programs using synthetic notch receptors. Cell. 2016;167:419\u201332.e16.","journal-title":"Cell"},{"key":"879_CR39","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1016\/j.cell.2016.01.011","volume":"164","author":"KT Roybal","year":"2016","unstructured":"Roybal KT, Rupp LJ, Morsut L, Walker WJ, McNally KA, Park JS, et al. Precision tumor recognition by T cells with combinatorial antigen-sensing circuits. Cell. 2016;164:770\u20139.","journal-title":"Cell"},{"key":"879_CR40","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1016\/S0960-9822(98)70300-8","volume":"8","author":"M Lecourtois","year":"1998","unstructured":"Lecourtois M, Schweisguth F. Indirect evidence for delta-dependent intracellular processing of notch in drosophila embryos. Curr Biol. 1998;8:771\u20134.","journal-title":"Curr Biol"},{"key":"879_CR41","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/S0002-9440(10)64513-0","volume":"157","author":"M K\u00f6mhoff","year":"2000","unstructured":"K\u00f6mhoff M, Guan Y, Shappell HW, Davis L, Jack G, Shyr Y, et al. Enhanced expression of cyclooxygenase-2 in high grade human transitional cell bladder carcinomas. Am J Pathol. 2000;157:29\u201335.","journal-title":"Am J Pathol"},{"key":"879_CR42","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1007\/s13402-021-00590-4","volume":"44","author":"C Kuang","year":"2021","unstructured":"Kuang C, Zhu Y, Guan Y, Xia J, Ouyang J, Liu G, et al. COX2 confers bone marrow stromal cells to promoting TNF\u03b1\/TNFR1\u03b2-mediated myeloma cell growth and adhesion. Cell Oncol. 2021;44:643\u201359.","journal-title":"Cell Oncol"},{"key":"879_CR43","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1038\/sj.mt.6300044","volume":"15","author":"SR Chaudhuri","year":"2007","unstructured":"Chaudhuri SR, Mallam JN, Ch\u00e9vez-Barrios P, Wadhwa L, Ng P, Hurwitz MY, et al. Modulation of adenoviral transduction in vitro and in vivo by hyaluronan and its receptor CD44. Mol Ther. 2007;15:566\u201370.","journal-title":"Mol Ther"},{"key":"879_CR44","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms5511","volume":"5","author":"JM Siegle","year":"2014","unstructured":"Siegle JM, Basin A, Sastre-Perona A, Yonekubo Y, Brown J, Sennett R, et al. SOX2 is a cancer-specific regulator of tumour initiating potential in cutaneous squamous cell carcinoma. Nat Commun. 2014;5:4511.","journal-title":"Nat Commun"},{"key":"879_CR45","doi-asserted-by":"publisher","first-page":"9012369","DOI":"10.1155\/2016\/9012369","volume":"2016","author":"B Sainz Jr","year":"2016","unstructured":"Sainz B Jr, Carron E, Vallespin\u00f3s M, Machado HL. Cancer stem cells and macrophages: implications in tumor biology and therapeutic strategies. Mediators Inflamm. 2016;2016:9012369.","journal-title":"Mediators Inflamm"},{"key":"879_CR46","doi-asserted-by":"publisher","first-page":"5514","DOI":"10.1091\/mbc.e05-05-0410","volume":"16","author":"TY El Sayegh","year":"2005","unstructured":"El Sayegh TY, Arora PD, Fan L, Laschinger CA, Greer PA, McCulloch CA, et al. Phosphorylation of N-cadherin-associated cortactin by Fer kinase regulates N-cadherin mobility and intercellular adhesion strength. Mol Biol Cell. 2005;16:5514\u201327.","journal-title":"Mol Biol Cell"},{"key":"879_CR47","first-page":"3177","volume":"6","author":"JP Rodrigo","year":"2000","unstructured":"Rodrigo JP, Garc\u00eda LA, Ramos S, Lazo PS, Su\u00e1rez C. EMS1 gene amplification correlates with poor prognosis in squamous cell carcinomas of the head and neck. Clin Cancer Res. 2000;6:3177\u201382.","journal-title":"Clin Cancer Res"},{"key":"879_CR48","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1016\/j.cell.2007.11.019","volume":"131","author":"K Takahashi","year":"2007","unstructured":"Takahashi K, Tanabe K, Ohnuki M, Narita M, Ichisaka T, Tomoda K, et al. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell. 2007;131:861\u201372.","journal-title":"Cell"},{"key":"879_CR49","doi-asserted-by":"publisher","DOI":"10.1186\/s12964-024-01475-3","volume":"22","author":"T Huang","year":"2024","unstructured":"Huang T, You Q, Huang D, Zhang Y, He Z, Shen X, et al. A positive feedback between PDIA3P1 and OCT4 promotes the cancer stem cell properties of esophageal squamous cell carcinoma. Cell Commun Signal. 2024;22:60.","journal-title":"Cell Commun Signal"},{"key":"879_CR50","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1002\/jcp.28963","volume":"235","author":"SS Yu","year":"2020","unstructured":"Yu SS, Cirillo N. The molecular markers of cancer stem cells in head and neck tumors. J Cell Physiol. 2020;235:65\u201373.","journal-title":"J Cell Physiol"},{"key":"879_CR51","first-page":"227","volume":"39","author":"MKA Md Akhir","year":"2017","unstructured":"Md Akhir MKA, Hussin H, Veerakumarasivam A, Choy CS, Abdullah MA, Abd Ghani F. Immunohistochemical expression of NANOG in urothelial carcinoma of the bladder. Malays J Pathol. 2017;39:227\u201334.","journal-title":"Malays J Pathol"},{"key":"879_CR52","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1007\/s12672-024-01173-z","volume":"15","author":"DE Bogale","year":"2024","unstructured":"Bogale DE. The roles of FGFR3 and c-MYC in urothelial bladder cancer. Discov Oncol. 2024;15:295.","journal-title":"Discov Oncol"},{"key":"879_CR53","doi-asserted-by":"publisher","first-page":"6075","DOI":"10.1158\/1078-0432.CCR-04-2419","volume":"11","author":"H Biliran Jr","year":"2005","unstructured":"Biliran H Jr, Wang Y, Banerjee S, Xu H, Heng H, Thakur A, et al. Overexpression of cyclin D1 promotes tumor cell growth and confers resistance to cisplatin-mediated apoptosis in an elastase-myc transgene-expressing pancreatic tumor cell line. Clin Cancer Res. 2005;11:6075\u201386.","journal-title":"Clin Cancer Res"},{"key":"879_CR54","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2020.113922","volume":"175","author":"N Kachamakova-Trojanowska","year":"2020","unstructured":"Kachamakova-Trojanowska N, Podkalicka P, Bogacz T, Barwacz S, J\u00f3zkowicz A, Dulak J, et al. HIF-1 stabilization exerts anticancer effects in breast cancer cells in vitro and in vivo. Biochem Pharmacol. 2020;175:113922.","journal-title":"Biochem Pharmacol"},{"key":"879_CR55","doi-asserted-by":"publisher","first-page":"362","DOI":"10.30699\/ijp.2021.138671.2518","volume":"16","author":"A Sadaf","year":"2021","unstructured":"Sadaf A, Rahman MZ, Bhattacharjee P, Ahamad MSU, Nasreen S. Significance of vascular endothelial growth factor expression in the bladder urothelial carcinoma and Its association with tumor grade and invasiveness. Iran J Pathol. 2021;16:362\u201369.","journal-title":"Iran J Pathol"},{"key":"879_CR56","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1111\/j.1365-2559.2010.03566.x","volume":"56","author":"L Gossage","year":"2010","unstructured":"Gossage L, Zaitoun A, Fareed KR, Turley H, Aloysius M, Lobo DN, et al. Expression of key hypoxia sensing prolyl-hydroxylases PHD1, -2 and -3 in pancreaticobiliary cancer. Histopathology. 2010;56:908\u201320.","journal-title":"Histopathology"},{"key":"879_CR57","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-021-03505-1","volume":"12","author":"X Bao","year":"2021","unstructured":"Bao X, Zhang J, Huang G, Yan J, Xu C, Dou Z, et al. The crosstalk between HIFs and mitochondrial dysfunctions in cancer development. Cell Death Dis. 2021;12:215.","journal-title":"Cell Death Dis"},{"key":"879_CR58","doi-asserted-by":"publisher","first-page":"1865","DOI":"10.2147\/CMAR.S166136","volume":"10","author":"M Okazaki","year":"2018","unstructured":"Okazaki M, Fushida S, Tsukada T, Kinoshita J, Oyama K, Miyashita T, et al. The effect of HIF-1\u03b1 and PKM1 expression on acquisition of chemoresistance. Cancer Manag Res. 2018;10:1865\u201374.","journal-title":"Cancer Manag Res"},{"key":"879_CR59","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1002\/(SICI)1096-9896(199910)189:2<194::AID-PATH426>3.0.CO;2-P","volume":"189","author":"Y Takano","year":"1999","unstructured":"Takano Y, Kato Y, Masuda M, Ohshima Y, Okayasu I. Cyclin D2, but not cyclin D1, overexpression closely correlates with gastric cancer progression and prognosis. J Pathol. 1999;189:194\u2013200.","journal-title":"J Pathol"},{"key":"879_CR60","doi-asserted-by":"publisher","DOI":"10.1007\/s13205-022-03225-z","volume":"12","author":"AP Ware","year":"2022","unstructured":"Ware AP, Kabekkodu SP, Chawla A, Paul B, Satyamoorthy K. Diagnostic and prognostic potential clustered miRNAs in bladder cancer. 3 Biotech. 2022;12:173.","journal-title":"3 Biotech"},{"key":"879_CR61","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1016\/S0090-4295(99)00474-4","volume":"55","author":"S Chang","year":"2000","unstructured":"Chang S, Lee S, Lee C, Kim JI, Kim Y. Expression of the human erythrocyte glucose transporter in transitional cell carcinoma of the bladder. Urology. 2000;55:448\u201352.","journal-title":"Urology"},{"key":"879_CR62","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2407-9-241","volume":"9","author":"FY Chung","year":"2009","unstructured":"Chung FY, Huang MY, Yeh CS, Chang HJ, Cheng TL, Yen LC, et al. GLUT1 gene is a potential hypoxic marker in colorectal cancer patients. BMC Cancer. 2009;9:241.","journal-title":"BMC Cancer"},{"key":"879_CR63","doi-asserted-by":"publisher","first-page":"982","DOI":"10.3390\/cancers15030982","volume":"15","author":"J Afonso","year":"2023","unstructured":"Afonso J, Gon\u00e7alves C, Costa M, Ferreira D, Santos L, Longatto-Filho A, et al. Glucose metabolism reprogramming in bladder cancer: hexokinase 2 (HK2) as prognostic biomarker and target for bladder cancer therapy. Cancers (Basel). 2023;15:982.","journal-title":"Cancers (Basel)"}],"container-title":["Cancer Gene Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41417-025-00879-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41417-025-00879-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41417-025-00879-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,30]],"date-time":"2025-03-30T07:17:27Z","timestamp":1743319047000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41417-025-00879-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,26]]},"references-count":63,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,3]]}},"alternative-id":["879"],"URL":"https:\/\/doi.org\/10.1038\/s41417-025-00879-8","relation":{},"ISSN":["0929-1903","1476-5500"],"issn-type":[{"value":"0929-1903","type":"print"},{"value":"1476-5500","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,26]]},"assertion":[{"value":"19 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 January 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 February 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 February 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}